Advertisement
Screener

TALPHERA, INC. (TLPH) Stock Issued During Period, Value, Employee Stock Purchase Plan

1.9 / 5 stars · 28/75 Roast Me

TALPHERA, INC. Stock Issued During Period, Value, Employee Stock Purchase Plan

New shares the company issued (share-based compensation, option exercises, employee stock purchase plans, new issues, acquisitions), as filed in its 10-Q and 10-K XBRL statement of shareholders' equity. This is the dilution side; Issuer Repurchases is the other side.

  • TALPHERA, INC. stock issued during period, value, employee stock purchase plan for the quarter ending 2026-03-31 was $21.00K, a 61.54% increase year-over-year.
  • TALPHERA, INC. stock issued during period, value, employee stock purchase plan for the quarter ending 2025-09-30 was $12.00K, a 60.00% decline year-over-year.
  • TALPHERA, INC. stock issued during period, value, employee stock purchase plan for the quarter ending 2025-06-30 was $4.35M.
  • TALPHERA, INC. stock issued during period, value, employee stock purchase plan for the quarter ending 2025-03-31 was $13.00K, a 7.14% decline year-over-year.
  • TALPHERA, INC. stock issued during period, value, employee stock purchase plan for fiscal 2025 was $39.00K, a 11.36% decline from fiscal 2024.
  • TALPHERA, INC. stock issued during period, value, employee stock purchase plan for fiscal 2024 was $44.00K, a 2.22% decline from fiscal 2023.
  • TALPHERA, INC. stock issued during period, value, employee stock purchase plan for fiscal 2023 was $45.00K, a 39.19% decline from fiscal 2022.
  • TALPHERA, INC. stock issued during period, value, employee stock purchase plan for fiscal 2022 was $74.00K.
Period endStock Issued During Period, Value, Employee Stock Purchase Plan 3 monthStock Issued During Period, Value, Employee Stock Purchase Plan 12 month
2026-03-31$21.00K
10-Q · filed 2026-08-12
2025-12-31$39.00K
10-K · filed 2026-03-23
2025-09-30$12.00K
10-Q · filed 2025-11-12
2025-06-30$4.35M
10-Q · filed 2026-08-12
2025-03-31$13.00K
10-Q · filed 2026-08-12
2024-12-31$44.00K
10-K · filed 2026-03-23
2024-09-30$30.00K
10-Q · filed 2025-11-12
2024-03-31$14.00K
10-Q · filed 2025-11-12
2023-12-31$45.00K
10-K · filed 2025-03-31
2023-09-30$14.00K
10-Q · filed 2024-11-13
2023-03-31$31.00K
10-Q · filed 2024-11-13
2022-12-31$74.00K
10-K · filed 2024-03-06
2022-09-30$16.00K
10-Q · filed 2023-11-14
2022-03-31$58.00K
10-Q · filed 2023-11-14
2021-12-31$301.00K
8-K · filed 2023-08-01
2021-09-30$109.00K
10-Q · filed 2022-11-14
2021-03-31$192.00K
10-Q · filed 2022-11-14
2020-12-31$372.00K
10-K · filed 2022-03-10
2020-09-30$154.00K
10-Q · filed 2021-11-15
2020-03-31$218.00K
10-Q · filed 2021-11-15
2019-12-31$473.00K
10-K · filed 2021-03-15
2019-09-30$234.00K
10-Q · filed 2020-11-05
2019-03-31$239.00K
10-Q · filed 2020-11-05
2018-12-31$275.00K
10-K · filed 2021-03-15
2018-09-30$134.00K
10-Q · filed 2019-11-07
2018-03-31$141.00K
10-Q · filed 2019-11-07
2017-12-31$246.00K
10-K · filed 2020-03-16
2016-12-31$179.00K
10-K · filed 2019-03-07
2015-12-31$429.00K
10-K · filed 2018-03-09
2014-12-31$362.00K
10-K · filed 2017-03-03
2013-12-31$219.00K
10-K · filed 2016-03-07
2012-12-31$169.00K
10-K · filed 2015-03-13
2011-12-31$139.00K
10-K · filed 2014-03-17

Similar stocks

Stock NameCountryMarket CapPE Ratio
CalciMedica, Inc. (CALC)United States$0.061B-1.42
Skye Bioscience, Inc. (SKYE)United States$0.061B-0.48
Boundless Bio, Inc. (BOLD)United States$0.059B-0.88
NOMAD POWER SOLUTIONS, INC. (NMAD)United States$0.058B
Rein Therapeutics, Inc. (RNTX)United States$0.063B-1.76
Annovis Bio, Inc. (ANVS)United States$0.056B-1.58
HYPERION DEFI, INC. (HYPD)United States$0.065B
XBiotech Inc. (XBIT)United States$0.066B-1.56
HERON THERAPEUTICS, INC. /DE/ (HRTX)United States$0.055B-2.38
Clene Inc. (CLNN)United States$0.054B-1.99